Description

Glixomet SRV Tablets
Glimepiride 2 mg + Metformin HCl (SR) 500 mg + Voglibose 0.3 mg:
Empowering precision in diabetes management, this advanced triple-combination therapy is thoughtfully designed to support comprehensive glycemic control through three complementary mechanisms of action:
Glimepiride helps enhance insulin secretion for effective glucose regulation
Metformin (SR) improves insulin sensitivity and reduces hepatic glucose output
Voglibose delays carbohydrate absorption, minimizing postprandial glucose spikes
Together, this synergistic formulation offers a holistic approach to blood sugar management, helping improve overall glycemic stability when prescribed appropriately.
Manufactured under stringent quality standards, this formulation ensures consistent efficacy, safety, and patient compliance with a convenient dosing profile.
⚠️ Important Medical Disclaimer
This is a prescription-only medication.
Indication, dosage, and duration should be strictly as advised by a Registered Medical Practitioner.
Do not self-medicate.